How often should you get blood work done? The answer depends on your age, risk factors, existing conditions, and family history. Yet most people either test too rarely — waiting until symptoms force them into a clinic — or too often, repeating tests monthly without clinical justification.
Evidence-based screening guidelines exist precisely to solve this problem. Organizations like the U.S. Preventive Services Task Force (USPSTF), the American Heart Association (AHA), the American Cancer Society (ACS), and the American Diabetes Association (ADA) publish recommendations based on decades of population data.
This guide consolidates their recommendations into a single, practical screening schedule organized by age.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Your individual risk profile may require different screening intervals. Always consult your healthcare provider.
The Principle Behind Screening Intervals
Screening intervals are not arbitrary. They are calculated based on:
- Disease prevalence at a given age — how common a condition is
- Rate of progression — how quickly an abnormality becomes dangerous
- Lead time — how far in advance a test can detect a problem before symptoms appear
- Benefit vs. harm — whether early detection actually improves outcomes
For example, lipid screening every 5 years is adequate for low-risk adults under 40 because atherosclerosis progresses slowly. But HbA1c screening every 3 years for overweight adults over 35 reflects the faster progression from prediabetes to diabetes. The goal: test often enough to catch problems early, but not so often that you generate false positives and unnecessary interventions.
Ages 18–25: The Baseline Window
For most healthy young adults without risk factors, the focus is on establishing baseline values.
Recommended Tests and Frequency
| Test |
Frequency |
Source |
| CBC |
Once as baseline, then as needed |
General practice |
| Basic Metabolic Panel |
Once as baseline |
General practice |
| Lipid Panel |
Once between 17–21 |
NHLBI, AHA |
| Fasting Glucose |
Once as baseline if overweight |
USPSTF |
| STI Screening |
Annually if sexually active |
CDC |
| Blood Pressure |
At every healthcare visit |
USPSTF (Grade A) |
Key Takeaway
At this age, a single comprehensive panel creates your personal reference ranges. These numbers become invaluable as you age — a "normal" result means something different when you know your own baseline.
If all results are normal and you have no risk factors, repeating blood work every 2–3 years is sufficient.
Ages 25–35: Annual Habit Formation
The late 20s and early 30s are when metabolic changes begin. Insulin sensitivity may start declining, cholesterol levels drift upward, and iron stores shift. This is also when most people establish (or neglect) the habit of regular testing.
Recommended Tests and Frequency
| Test |
Frequency |
Source |
| CBC with Differential |
Annually |
General practice |
| Comprehensive Metabolic Panel |
Annually |
General practice |
| Lipid Panel |
Every 4–6 years (low risk); annually if borderline |
AHA |
| HbA1c or Fasting Glucose |
Every 3 years if overweight/obese; more often with risk factors |
USPSTF (Grade B for 35–70) |
| TSH |
Every 5 years; annually with symptoms or family history |
ATA |
| Vitamin D |
Annually in at-risk groups (northern climates, dark skin, indoor lifestyle) |
Endocrine Society |
| Iron/Ferritin |
Annually for menstruating women; as baseline for men |
General practice |
When to Increase Frequency
Move to annual testing for all core markers if you have:
- BMI above 25
- Family history of heart disease or diabetes
- Sedentary lifestyle
- Regular alcohol or nicotine use
- Chronic stress or sleep deprivation
Ages 35–45: The Critical Transition
The USPSTF explicitly recommends several screenings beginning in this window. This is when population-level disease risk increases significantly.
Recommended Tests and Frequency
| Test |
Frequency |
Source |
| Full Annual Panel (CBC, CMP, lipids, HbA1c, TSH) |
Annually |
Composite recommendation |
| HbA1c |
Every 3 years (normal BMI); annually (overweight/obese) |
USPSTF (Grade B) |
| Lipid Panel |
Annually if prior results borderline; every 2–3 years if optimal |
AHA |
| Hormone Panel |
As needed (symptoms of deficiency) |
Endocrine Society |
| Liver Panel (AST, ALT, GGT) |
Annually |
General practice |
| Hepatitis C |
One-time screening for all adults 18–79 |
USPSTF (Grade B) |
| Vitamin D, B12 |
Annually |
General practice |
New Additions at This Stage
- Statin eligibility: The AHA/ACC recommends calculating 10-year ASCVD risk for adults aged 40–75. This requires current lipid values, blood pressure, and diabetes status. Annual lipids become standard.
- Prediabetes monitoring: If HbA1c is 5.7–6.4%, testing every 6–12 months is warranted to track progression.
- Annual health checkup planning: At this age, structuring your blood work into a consistent annual panel saves time and money.
Ages 45–55: Expanded Surveillance
Cancer screening enters the picture alongside intensified metabolic monitoring.
Recommended Tests and Frequency
| Test |
Frequency |
Source |
| Full Annual Panel |
Annually |
Composite |
| HbA1c |
Every 1–3 years depending on risk |
USPSTF/ADA |
| Lipid Panel |
Annually |
AHA |
| PSA (men, shared decision) |
Discuss starting at 55 (or 40–45 with high risk) |
USPSTF/AUA |
| hsCRP |
Annually if cardiovascular risk factors present |
AHA |
| Kidney Function (eGFR, creatinine) |
Annually |
KDIGO |
| Colorectal Cancer Screening |
Starting at 45 (colonoscopy or stool DNA) |
ACS (updated 2018) |
| Uric Acid |
Annually if history of gout or kidney stones |
General practice |
Medication Monitoring
If you are taking any of these common medications, blood work frequency increases:
- Statins: Lipid panel + liver enzymes every 6–12 months
- Metformin: B12 annually; metabolic panel every 6 months
- Thyroid medication: TSH every 6–12 months until stable, then annually
- Blood pressure medications: Electrolytes and kidney function every 6–12 months
- NSAIDs (chronic use): Kidney function and CBC every 6 months
Ages 55–65: Intensive Monitoring
This decade carries the highest combined risk for cardiovascular events, metabolic complications, and cancer diagnosis. Screening frequency increases accordingly.
Recommended Tests and Frequency
| Test |
Frequency |
Source |
| Full Annual Panel |
Every 6–12 months |
Composite |
| Lipid Panel |
Every 6–12 months if on treatment |
AHA |
| HbA1c |
Every 6–12 months |
ADA |
| Kidney Panel (eGFR, BUN, creatinine, electrolytes) |
Every 6–12 months |
KDIGO |
| Hemoglobin/Hematocrit |
Every 6–12 months (anemia risk rises) |
General practice |
| PSA (men, 55–69) |
Annually if opted in after shared decision |
USPSTF |
| TSH |
Annually |
ATA |
| Vitamin D + B12 |
Annually |
Endocrine Society |
| Coagulation (if on anticoagulants) |
Per physician schedule |
Standard of care |
Key Consideration
At this age, tracking trends is more important than individual snapshots. A rising creatinine over three tests, a slowly climbing HbA1c, or a gradual decline in hemoglobin tells a story that a single test cannot.
Ages 65+: Geriatric Screening Adjustments
After 65, screening recommendations become more individualized. Life expectancy, functional status, and patient preferences play a larger role.
Key Changes
- Some cancer screenings stop: USPSTF recommends against routine PSA after 70. Colorectal screening may stop at 75-85 depending on health status. Cervical screening stops at 65 if prior results are normal.
- Metabolic monitoring continues: Diabetes, kidney disease, thyroid dysfunction, and nutritional deficiencies have no age cutoff.
- Medication reviews increase: Polypharmacy (multiple medications) is common, making regular lab monitoring essential to catch drug-related kidney or liver damage.
- Nutritional screening intensifies: B12 deficiency, iron deficiency, and vitamin D deficiency become more prevalent with reduced absorption and dietary intake.
Recommended Frequency
Core blood work every 6 months for adults over 65 with chronic conditions. Annually for healthy, active adults without medication.
Summary: Testing Frequency at a Glance
| Age Group |
Core Panel Frequency |
Lipids |
HbA1c |
TSH |
| 18–25 |
Baseline + as needed |
Once |
If overweight |
If symptomatic |
| 25–35 |
Every 1–2 years |
Every 4–6 years |
Every 3 years |
Every 5 years |
| 35–45 |
Annually |
Every 1–3 years |
Every 1–3 years |
Every 2–5 years |
| 45–55 |
Annually |
Annually |
Annually |
Annually |
| 55–65 |
Every 6–12 months |
Every 6–12 months |
Every 6–12 months |
Annually |
| 65+ |
Every 6–12 months |
Every 6–12 months |
Every 6–12 months |
Annually |
Get Your Results Interpreted
Knowing when to test is half the equation. Understanding what the results mean is the other half.
Upload your blood test results to Evallume for a clear, personalized interpretation. Whether it is your first baseline panel or your annual checkup at 55, the analysis explains every value, flags abnormalities, and shows how your results compare to standard reference ranges.
Disclaimer: Evallume provides educational interpretation and does not replace a consultation with your physician. Always discuss significant findings with a qualified healthcare provider.